Human immunodeficiency virus type 1 (HIV-1) targets important cells of our immune system, making infected individuals more ...

Curing HIV will be harder than curing cancer. But new research is promising.HIV is "like a time bomb," said James Riley, a ...

Pseudoscience has recently been reemerging in the US. While much of it concerns vaccines, an "oldie" is again making the ...

A new chemical compound has been making a big impression in the fight against cancer in recent years. Now it seems EBC-46, ...

Researchers at the Max Planck Institute of Biophysics and Heidelberg University have observed largely intact HIV-1 capsids as ...

2024 — An experimental drug originally developed to treat cancer may help clear HIV from infected cells in the brain, according to a new study. By targeting infected cells in the brain ...

HIV has become a more manageable condition in recent years, but a full cure remains elusive. Now, scientists have found ...

Determinants of HIV cell tropism & chemokine receptor usage ... exhibit a strong resistance to HIV infection and delayed progression to AIDS, respectively. A single-nucleotide polymorphism in ...

Stanford researchers highlight the potential of EBC-46, a compound derived from Australia’s blushwood tree, in eradicating ...

Frazer School student Sophia Rong’s passion for science began in seventh grade at Lincoln Middle School when she was assigned ...

CAR T cell therapy is one of the most promising new cancer treatments to emerge in recent years. It involves removing a ...